Trials / Completed
CompletedNCT03999528
14-3-3η Protein, Disease Activity and Bone Mineral Density, in Female Patients With Rheumatoid Arthritis
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 45 (actual)
- Sponsor
- Al-Azhar University · Academic / Other
- Sex
- Female
- Age
- 16 Years
- Healthy volunteers
- Accepted
Summary
Is to investigate the relation between 14-3-3η protein, disease activity, and bone mineral density in female patients with rheumatoid arthritis.
Detailed description
Methods: all patients in the study will subject to: * Clinical assessment, WT, Height ,BMI, parity, medications, * DAS 28. * Serum 14-3-3η protein. * DEXA scan. Grouping: * Group I: RA Patients with low BMD. * Group II: RA Patients with normal BMD. * Group III: normal control.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DIAGNOSTIC_TEST | 14-3-3η Protein assay | blood sampling for assessment of serum 14-3-3η Protein |
Timeline
- Start date
- 2019-05-01
- Primary completion
- 2019-08-01
- Completion
- 2019-08-01
- First posted
- 2019-06-26
- Last updated
- 2020-06-09
Locations
1 site across 1 country: Egypt
Source: ClinicalTrials.gov record NCT03999528. Inclusion in this directory is not an endorsement.